Chronic leptin treatment sensitizes MCF-7 breast cancer cells to estrogen

Cellular Physiology and Biochemistry

Volumn 28, Issue 5, 2011, Pages 823-832

  Valle, Adamo ^a   Sastre Serra, Jorge ^a   Oliver, Jordi ^a   Roca, Pilar ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Breast cancer; Estrogen; Estrogen receptor; Leptin; MCF 7; Obesity

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; JANUS KINASE 2; LEPTIN; STAT3 PROTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 83755178198     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335796     Document Type: Article

References (48)

1. Calle EE, Thun MJ: Obesity and cancer. Oncogene 2004;23:6365-6378. (Pubitemid 39265505)
2. Cleary MP, Maihle NJ: The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997;216:28-43.
3. Willett WC: Fat, energy and breast cancer. J Nutr 1997;127:921S-923S. 4 Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: The richard and hinda rosenthal foundation award lecture. Cancer Res 1988;48:246-253. (Pubitemid 27209469)
4. Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: The richard and hinda rosenthal foundation award lecture. Cancer Res 1988;48:246-253.
5. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS: A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-197.
6. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD: Insulin, insulin-like growth factor-i, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
7. Jarde T, Perrier S, Vasson MP, Caldefie-Chezet F: Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 2011;47:33-43.
8. Vona-Davis L, Rose DP: Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 2009;20:193-201.
9. Ahima RS, Flier JS: Leptin. Annu Rev Physiol 2000;62:413-437. (Pubitemid 30618269)
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432. (Pubitemid 24365442)
11. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, Lammer C, Peiser C, Lang RE: Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996;137:1501-1504. (Pubitemid 26098620)
12. Cohen MM Jr: Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. Am J Med Genet A 2006;140:515-524. (Pubitemid 43376325)
13. Sweeney G: Leptin signalling. Cell Signal 2002;14:655-663. (Pubitemid 34518619)
14. Fantuzzi G, Faggioni R: Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000;68:437-446.
15. Goumenou AG, Matalliotakis IM, Koumantakis GE, Panidis DK: The role of leptin in fertility. Eur J Obstet Gynecol Reprod Biol 2003;106:118-124. (Pubitemid 36120454)
16. Wauters M, Considine RV, Van Gaal LF: Human leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;143:293-311.
17. Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP, Maihle NJ: Leptin receptordeficient mmtv-tgf-alpha/lepr(db)lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood) 2004;229:182-193. (Pubitemid 38146562)
18. Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA, Juneja SC, Grande JP, Maihle NJ: Genetically obese mmtv-tgf-alpha/lep(ob) lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 2003;77:205-215. (Pubitemid 36197635)
19. Hu X, Juneja SC, Maihle NJ, Cleary MP: Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002;94:1704-1711. (Pubitemid 35446839)
20. Chen C, Chang YC, Liu CL, Chang KJ, Guo IC: Leptin-induced growth of human zr-75-1 breast cancer cells is associated with up-regulation of cyclin d1 and cmyc and down-regulation of tumor suppressor p53 and p21waf1/cip1. Breast Cancer Res Treat 2006;98:121-132. (Pubitemid 44050760)
21. Perera CN, Chin HG, Duru N, Camarillo IG: Leptin-regulated gene expression in mcf-7 breast cancer cells: Mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol 2008;199:221-233.
22. Perera CN, Spalding HS, Mohammed SI, Camarillo IG: Identification of proteins secreted from leptin stimulated mcf-7 breast cancer cells: A dual proteomic approach. Exp Biol Med (Maywood) 2008;233:708-720.
23. Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, Rago V, Montanaro D, Maggiolini M, Panno ML, Ando S: Leptin induces, via erk1/erk2 signal, functional activation of estrogen receptor alpha in mcf-7 cells. J Biol Chem 2004;279:19908-19915. (Pubitemid 38623433)
24. Fusco R, Galgani M, Procaccini C, Franco R, Pirozzi G, Fucci L, Laccetti P, Matarese G: Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: Molecular basis for a novel therapeutic setting. Endocr Relat Cancer 2010;17:373-382.
25. Garofalo C, Sisci D, Surmacz E: Leptin interferes with the effects of the antiestrogen ici 182,780 in mcf-7 breast cancer cells. Clin Cancer Res 2004;10:6466-6475. (Pubitemid 39346542)
26. Garofalo C, Surmacz E: Leptin and cancer. J Cell Physiol 2006;207:12-22.
27. Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, Ando S: Leptin enhances, via ap-1, expression of aromatase in the mcf-7 cell line. J Biol Chem 2003;278:28668-28676. (Pubitemid 36935773)
28. Magoffin DA, Weitsman SR, Aagarwal SK, Jakimiuk AJ: Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. Ginekol Pol 1999;70:1-7.
29. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, Giudicelli Y: Leptin mediates a proliferative response in human mcf7 breast cancer cells. Biochem Biophys Res Commun 2002;293:622-628. (Pubitemid 34694255)
30. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS: Identification of socs-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-625. (Pubitemid 128374698)
31. Bahrenberg G, Behrmann I, Barthel A, Hekerman P, Heinrich PC, Joost HG, Becker W: Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol Endocrinol 2002;16:859-872. (Pubitemid 34297753)
32. Ghilardi N, Skoda RC: The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 1997;11:393-399. (Pubitemid 27147006)
33. Harris HA, Bruner-Tran KL, Zhang X, Osteen KG, Lyttle CR: A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005;20:936-941. (Pubitemid 40667838)
34. Hartman J, Lindberg K, Morani A, Inzunza J, Strom A, Gustafsson JA: Estrogen receptor beta inhibits angiogenesis and growth of t47d breast cancer xenografts. Cancer Res 2006;66:11207-11213. (Pubitemid 46009948)
35. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC: Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a g2 cell cycle arrest. Cancer Res 2004;64:423-428. (Pubitemid 38114127)
36. Speirs V, Kerin MJ: Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 2000;87:405-409. (Pubitemid 30192946)
37. Cleary MP, Grossmann ME: Minireview: Obesity and breast cancer: The estrogen connection. Endocrinology 2009;150:2537-2542.
38. Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-616. (Pubitemid 34498648)
39. Thomas HV, Reeves GK, Key TJ: Endogenous estrogen and postmenopausal breast cancer: A quantitative review. Cancer Causes Control 1997;8:922-928. (Pubitemid 27485468)
40. Langendonk JG, Pijl H, Toornvliet AC, Burggraaf J, Frolich M, Schoemaker RC, Doornbos J, Cohen AF, Meinders AE: Circadian rhythm of plasma leptin levels in upper and lower body obese women: Influence of body fat distribution and weight loss. J Clin Endocrinol Metab 1998;83:1706-1712. (Pubitemid 28501046)
41. Ishikawa M, Kitayama J, Nagawa H: Enhanced expression of leptin and leptin receptor (ob-r) in human breast cancer. Clin Cancer Res 2004;10:4325-4331. (Pubitemid 38878870)
42. Orban Z, Remaley AT, Sampson M, Trajanoski Z, Chrousos GP: The differential effect of food intake and betaadrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 1999;84:2126-2133. (Pubitemid 30647044)
43. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG, Kushner PJ: Opposing action of estrogen receptors alpha and beta on cyclin d1 gene expression. J Biol Chem 2002;277:24353-24360. (Pubitemid 34951956)
44. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA: A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001;98:6330-6335. (Pubitemid 32492315)
45. Sotoca AM, van den Berg H, Vervoort J, van der Saag P, Strom A, Gustafsson JA, Rietjens I, Murk AJ: Influence of cellular eralpha/erbeta ratio on the eralphaagonist induced proliferation of human t47d breast cancer cells. Toxicol Sci 2008;105:303-311.
46. Yu W, Gu JC, Liu JZ, Wang SH, Wang Y, Zhang ZT, Ma XM, Song MM: Regulation of estrogen receptors alpha and beta in human breast carcinoma by exogenous leptin in nude mouse xenograft model. Chin Med J (Engl) 2010;123:337-343.
47. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli. Clin Cancer Res 2006;12:1447-1453.
48. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP: Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive earlystage breast cancer. J Natl Cancer Inst 2003;95:1467-1476. (Pubitemid 37279332)